Literature DB >> 17496927

Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.

G Oxford1, S C Smith, G Hampton, D Theodorescu.   

Abstract

Although the monomeric GTPases RalA and RalB have been shown to regulate a variety of transcription factors, little is known regarding the differences or similarities in transcriptional programs regulated by RalA compared to RalB. Further, the association of these transcriptional pathways to human carcinogenesis and progression remains unclear. Here, we studied the role of RalA and/or RalB in transcriptional regulation by combining short interfering RNA depletion of Ral with gene expression profiling via microarray in the human bladder cancer cell line, UMUC-3. A large number of genes were found to be similarly modulated in cells with RalA and RalB depletion, suggesting that RalA and RalB impinge on overlapping transcriptional signaling pathways. However, smaller sets of genes were modulated by depletion of RalA or RalB, indicating that these closely related proteins also regulate nonoverlapping transcriptional pathways. Computational analysis of upstream sequences of genes modulated by Ral depletion identified Ras-responsive element-binding protein (RREB)-1, as a putative Ral transcriptional target, which we verified experimentally. Importantly, as a group, Ral-regulated probe sets identified here were disproportionally represented among those differentially expressed as a function of human bladder transformation. Taken together, these data strongly suggest that Ral family members mediate both common and specific transcriptional programs that are associated with human cancer and identify RREB-1 as a novel transcriptional effector of Ral.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17496927     DOI: 10.1038/sj.onc.1210521

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Jing Zou; Mohamed Mokhtar Desouki; Renty B Franklin
Journal:  J Gastrointest Cancer       Date:  2012-12

2.  Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.

Authors:  Leslie C Costello; Bernard A Levy; Mohamed M Desouki; Jing Zou; Omar Bagasra; Leslie A Johnson; Nader Hanna; Renty B Franklin
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 3.  A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Arch Biochem Biophys       Date:  2016-04-27       Impact factor: 4.013

4.  RREB1 transcription factor splice variants in urologic cancer.

Authors:  Matthew D Nitz; Michael A Harding; Steven C Smith; Shibu Thomas; Dan Theodorescu
Journal:  Am J Pathol       Date:  2011-07       Impact factor: 4.307

5.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

6.  Comparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.

Authors:  Dmytro M Havaleshko; Steven Christopher Smith; HyungJun Cho; Sooyoung Cheon; Charles R Owens; Jae K Lee; Lance A Liotta; Virginia Espina; Julia D Wulfkuhle; Emanuel F Petricoin; Dan Theodorescu
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

7.  The cytotoxic role of RREB1, ZIP3 zinc transporter, and zinc in human pancreatic adenocarcinoma.

Authors:  Renty B Franklin; Jing Zou; Leslie C Costello
Journal:  Cancer Biol Ther       Date:  2014-07-22       Impact factor: 4.742

8.  Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.

Authors:  Zhong Wu; HyungJun Cho; Garret M Hampton; Dan Theodorescu
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

9.  CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

Authors:  Shibu Thomas; Michael A Harding; Steven C Smith; Jonathan B Overdevest; Matthew D Nitz; Henry F Frierson; Scott A Tomlins; Glen Kristiansen; Dan Theodorescu
Journal:  Cancer Res       Date:  2012-08-27       Impact factor: 12.701

Review 10.  The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target.

Authors:  Steven Christopher Smith; Dan Theodorescu
Journal:  Urol Oncol       Date:  2009 Jan-Feb       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.